The comparison of unfractionated heparin and dalteparin during percutaneous coronary interventions - the results of a multicentric randomized study

Abstract

Use of LMWH during PTCA in stable angina. Evaluation of number, activity and aggregation response of platelets and trombin activity.

Difference in complication occurrence after PTCA in patients treated with UFH, and LMWH.

Keywords

• percutaneous coronary interventions
• unfractionated heparin
• low-molecular weight heparin
• dalteparin
• platelets